Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05841810 · ClinicalTrials.gov registry record · NA
Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement
A NA study of COVID-19, sponsored by University of California, San Diego.
- Active
- Registry status
- NA
- Development phase
- 398
- Enrollment target
- 4
- Study locations
NCT05841810: Active NA study of COVID-19, sponsored by University of California, San Diego.
NCT05841810 is a NA study of COVID-19 that is active but no longer recruiting, run by University of California, San Diego. The registered enrollment target is 398 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 4 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05841810, a NA study of COVID-19, is active but no longer recruiting, sponsored by University of California, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 398 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study will optimize, implement, and test the impact of our multicomponent health program that includes three primary implementation strategies (Cultural Weavers and co-creation, mHealth strategies using culturally meaningful text and voice messages, and care coordination). The investigators will use a participatory approach to engage community members in co-creating and optimizing our mHealth outreach and enhanced care coordination program components. The investigators will use a hybrid type 3 effectiveness-implementation sequential multiple assignment randomized trial (SMART) design to assess the impact of our multicomponent health program on implementation and outcome measures.
Primary Outcome
Clinical assessment of COVID-19 vaccine status based on the total number of COVID-19 vaccines received (initial + boosters).
Conditions Studied
Interventions
- OTHER mHealth Outreach
- OTHER Care Coordination
Study Locations (4)
California
- San Ysidro Health Medical Center - El Cajon - El Cajon
- Escondido Family Medicine - Escondido
- University of California San Diego - La Jolla
- Community Heights Family Medicine - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 398 participants |
| Start Date | 2024-08-20 |
| Est. Completion | 2027-06-30 |
| Phase | NA |
What the registry record for NCT05841810 still lists
NCT05841810 is an interventional study that assigns participants to a tested intervention. The registered 398 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (99% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 2 interventions - of which mHealth Outreach is the first listed.
NCT05841810 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05841810 about?
NCT05841810 is a clinical study titled "Working Towards Empowered Community-driven Approaches to Increase Vaccination and Preventive Care Engagement". This study will optimize, implement, and test the impact of our multicomponent health program that includes three primary implementation strategies (Cultural Weavers and co-creation, mHealth strategies using culturally meaningful text and voice messages, and care coordination). The investigators wil...
What is the current status of trial NCT05841810?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 398 participants. The study started on 2024-08-20. Estimated completion is 2027-06-30.
What conditions does trial NCT05841810 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT05841810?
The interventions under investigation include: mHealth Outreach (OTHER), Care Coordination (OTHER).
Who is sponsoring clinical trial NCT05841810?
This trial is sponsored by University of California, San Diego, which has 775 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05841810 being conducted?
This trial has 4 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05841810's enrollment target sits among peer trials
398 125th of 298 higher than 174 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Music Mindfulness Study 2a.
RECRUITING · NA
-
Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS)
RECRUITING · NA
-
Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study
RECRUITING · NA
-
Evaluating the Impact of Social Music
RECRUITING · NA
-
The SINCERE Intervention to Address COVID-19 Health Disparities
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05365581 · 398 participants · Phase 1
A Study of ASP2138 Given by Itself or Given With Other Cancer Treatments in Adults With Stomach Cancer, Gastroesophageal Junction Cancer, or Pancreatic Cancer
- NCT03165734 · 399 participants · Phase 3
A Phase 3 Study of Pacritinib in Patients With Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post-Essential Thrombocythemia Myelofibrosis
- NCT05022862 · 399 participants · NA
Economic Incentives and vDOT for Latent Tuberculosis Infection
- NCT00601939 · 397 participants · NA
Effectiveness of Empowerment Group Sessions for Treating Suicidal African American Women in Abusive Relationships
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI